KIF2C and hepatocellular carcinoma: Chromatin immunoprecipitation (ChIP) assay confirmed the binding of endogenous TCF4 to the KIF2C promoter (Fig. 7F), indicating that KIF2C is a direct target of TCF4 in HCC cells.